NeoGenomics Q1 2025 Financials Filed
Ticker: NEO · Form: 10-Q · Filed: Apr 29, 2025 · CIK: 1077183
Sentiment: neutral
Topics: 10-Q, financials, earnings
Related Tickers: NEO
TL;DR
NEO Q1 2025 financials are in. Stock, capital, earnings detailed.
AI Summary
NeoGenomics Inc. reported its first quarter results for the period ending March 31, 2025. The company's filing details its financial position, including common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings as of both March 31, 2025, and December 31, 2024. Specific financial performance figures for the first quarter of 2025 and 2024 are also presented.
Why It Matters
This filing provides investors with the latest financial snapshot of NeoGenomics, crucial for understanding the company's performance and making informed investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the healthcare sector can be subject to regulatory and market risks.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Current quarter end)
- 2024-12-31 — Prior Year End Date (Previous year's financial position)
- 2025-01-01 to 2025-03-31 — Current Quarter Period (First quarter of 2025)
- 2024-01-01 to 2024-03-31 — Prior Year Quarter Period (First quarter of 2024)
Key Players & Entities
- NEOGENOMICS INC (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250429 (date) — Filing Date
- 742897368 (company) — EIN
- NV (company) — State of Incorporation
- 1231 (date) — Fiscal Year End
- 001-35756 (company) — SEC File Number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on April 29, 2025.
What is NeoGenomics Inc.'s fiscal year end?
NeoGenomics Inc.'s fiscal year ends on December 31.
What are some of the key financial components detailed in the filing for the period ending March 31, 2025?
The filing details components such as Common Stock, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Retained Earnings for the period ending March 31, 2025.
What is NeoGenomics Inc.'s SEC file number?
NeoGenomics Inc.'s SEC file number is 001-35756.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 29, 2025 regarding NEOGENOMICS INC (NEO).